ChemicalsMid capRs 15,982 crRs 24.9 cr traded a day
Close on 2026-08-21
626.75
−1.22%
52-week range10% of the way up
583.251,005.15
Market cap
15,982 cr
Revenue YoY
+12.3%
Q1 FY27
Profit YoY
-68.4%
Net margin
1.4%
-3.6pt vs a year ago
Growth trend
+13.4pt
vs last quarter’s YoY
1 month
-7.7%
Below 52w high
60.4%
RSI (14)
19
oversold
Daily swing
2.6%
average true range
Volume
0.8×
vs 20-day average
Traded
Rs 25 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−6.55%
1 month
−7.75%
3 months
−20.05%
6 months
−12.47%
1 year
−32.71%
The read
written from the numbers on this page
The evidence is mixed2 supporting, 3 against, 1 worth knowing
Supporting
revenue grew 12% year on year in the quarter ending 2026-06-30
net margin has widened from -0.6% to 1.4% across four quarters
Against
trading 13% below its 200-day average
at 10% of its 52-week range — nearly everyone who bought in the past year is underwater
down 33% over twelve months
Worth knowing
RSI at 19 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 721, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working1
Revenue +6.4% year on year, Rs 3,999 cr to Rs 4,255 cr.
+6.4%Rs 3,999 crRs 4,255 cr
Needs watching3
Net profit -77.5% year on year, Rs 267 cr to Rs 60 cr.
-77.5%Rs 267 crRs 60 cr
Profit grew slower than revenue, -77.5% against +6.4%.
-77.5%+6.4%
Net margin moved from 6.7% to 1.4%.
6.7%1.4%
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
1 of 47 matched on 2026-08-21
TATACHEM matches 1 of the 47 scans today, across 1 different kinds of evidence.
segments and revenue mix, as the company reports them
TATACHEM reports 3 business segments. The largest is Industrial Essentials at 52% of revenue in the quarter ending 2026-06-30.
SegmentRevenueSharevs a year ago
Industrial Essentials2,240 cr51.8%—
Living Essentials1,064 cr24.6%—
Farm Essentials1,022 cr23.6%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Quality of the business
balance sheet as at 2026-03-31
Return on equity
-10.1%
trailing profit over shareholders’ funds
Return on capital
-7.0%
pre-tax profit over equity plus borrowings
Debt to equity
0.38×
8,001 cr borrowed against 21,206 cr of equity
Net debt
7,620 cr
borrowings less cash
Receivable days
51
how long customers take to pay
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
145 sessions since 2026-02-02
43×
median 49×
56×
now 44×
TATACHEM trades at 44× trailing earnings, below its median of 49× over this window — 12% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 12% against the same quarter a year earlier
net margin widened from -61.5% to 1.4%
Going against it
profit dropped 68% year on year
revenue rose in 1 of the last 4 quarters
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
4,255
127
60
—
1.4%
Q4 FY26
2026-03-31 · consolidated
3,438
-2,015
-2,116
—
-61.5%
Q3 FY26
2025-12-31 · consolidated
3,550
-110
-69
3.65
-1.9%
Q3 FY25
2024-12-31 · consolidated
3,590
-36
-21
-2.08
-0.6%
Q2 FY25
2024-09-30 · consolidated
3,999
304
267
7.61
6.7%
Q1 FY25
2024-06-30 · consolidated
3,789
215
190
5.89
5.0%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-9.6%
Versus 200-day average-13.1%
Below 52-week high-37.6%
Above 52-week low+7.5%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)19.0
Higher closes in last 50 of 5
Six-month return−12.47%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.